These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32720697)

  • 1. Effectiveness of Combined Anti-programmed Death-ligand 1 Therapy and Radiotherapy for Metastatic Merkel Cell Carcinoma: Two Case Reports.
    Tsunoda K; Onishi M; Miura S; Amano H
    Acta Derm Venereol; 2020 Aug; 100(15):adv00237. PubMed ID: 32720697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunotherapy with ipilimumab plus nivolumab in metastatic PD-1/PD-L1-refractory Merkel cell carcinoma-a case report.
    Leven AS; Becker JC; Pöttgen C; Schadendorf D; Ugurel S; Tasdogan A
    Int J Dermatol; 2024 Feb; 63(2):e69-e71. PubMed ID: 38093413
    [No Abstract]   [Full Text] [Related]  

  • 3. Case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab.
    Shibayama Y; Kameda H; Ota S; Tsuchida K; Cho KY; Nakamura A; Miyoshi H; Atsumi T
    J Diabetes Investig; 2019 Sep; 10(5):1385-1387. PubMed ID: 30738003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for Merkel Cell Carcinoma.
    Nagase K; Narisawa Y
    Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases.
    Knackstedt R; Sussman TA; McCahon L; Song JM; Funchain P; Gastman B
    Ann Oncol; 2019 Aug; 30(8):1399-1400. PubMed ID: 31250007
    [No Abstract]   [Full Text] [Related]  

  • 6. Divergent response to PD-L1 inhibition in advanced Merkel cell carcinoma and cutaneous squamous cell carcinoma.
    Salzmann M; Löser C; Hassel JC
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):803-805. PubMed ID: 37066606
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers.
    Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A
    Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report.
    Cardis MA; Jiang H; Strauss J; Gulley JL; Brownell I
    BMC Cancer; 2019 Jun; 19(1):539. PubMed ID: 31164102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma.
    Joseph J; Zobniw C; Davis J; Anderson J; Trinh VA
    Ann Pharmacother; 2018 Sep; 52(9):928-935. PubMed ID: 29616562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy.
    Veness MJ
    J Clin Oncol; 2005 Oct; 23(28):7235-6; author reply 7237-8. PubMed ID: 16192613
    [No Abstract]   [Full Text] [Related]  

  • 11. Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
    Dasanu CA; Del Rosario M; Codreanu I; Hyams DM; Plaxe SC
    J Oncol Pharm Pract; 2019 Jan; 25(1):214-216. PubMed ID: 29933728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune checkpoint inhibition in Merkel cell carcinoma].
    Terheyden P; Mohr A; Langan EA
    Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel cell carcinoma of the anal canal: importance of radiotherapy.
    Coquard R
    Dis Colon Rectum; 2004 Feb; 47(2):256-7; author reply 257. PubMed ID: 15043301
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of programmed death-ligand expression in a case of Merkel cell carcinoma exhibiting complete regression after multiple metastases.
    Nakamura M; Magara T; Kobayashi Y; Kato H; Watanabe S; Morita A
    Br J Dermatol; 2019 May; 180(5):1228-1229. PubMed ID: 30431150
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction chemotherapy followed by radiotherapy in Merkel-cell carcinoma.
    Poon D; Yap SP; Mancer K; Quek ST; Soh LT
    Lancet Oncol; 2004 Aug; 5(8):509-10. PubMed ID: 15288240
    [No Abstract]   [Full Text] [Related]  

  • 16. Merkel cell carcinoma.
    Goessling W; McKee PH; Mayer RJ
    J Clin Oncol; 2002 Jan; 20(2):588-98. PubMed ID: 11786590
    [No Abstract]   [Full Text] [Related]  

  • 17. In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series.
    Xu MJ; Wu S; Daud AI; Yu SS; Yom SS
    J Immunother Cancer; 2018 May; 6(1):43. PubMed ID: 29848371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased programmed death ligand-1 expression in metastatic Merkel cell carcinoma associates with better prognosis.
    Nakamura M; Magara T; Nojiri Y; Nishihara H; Kato H; Teramoto Y; Yasuda M; Wada H; Ozawa T; Umemori Y; Ogata D; Kobayashi T; Hata M; Nagase K; Morita A
    J Dermatol Sci; 2020 Feb; 97(2):165-167. PubMed ID: 31902663
    [No Abstract]   [Full Text] [Related]  

  • 19. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
    Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P
    Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
    Baker M; Cordes L; Brownell I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.